Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|May 2, 2003
Synthesis and biological evaluation of new 2-(4,5-dihydro-1H-imidazol-2-yl)-3,4-dihydro-2H-1,4-benzoxazine derivativesFrédérique Touzeau, Axelle Arrault, Gérald Guillaumet, et al.
Journal of Vascular Research|January 4, 2005
Stent implantation activates RhoA in human arteries: inhibitory effect of rapamycinPatrice Guérin, Vincent Sauzeau, Malvyne Rolli-Derkinderen, et al.
Circulation|March 6, 2002
Evidence for synergy between alpha(2)-adrenergic and nonadrenergic mechanisms in central blood pressure regulationVéronique Bruban, Vanessa Estato, Stephan Schann, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 18, 2003
ACE-versus chymase-dependent angiotensin II generation in human coronary arteries: a matter of efficiency?Beril Tom, Ingrid M Garrelds, Elizabeth Scalbert, et al.
International Journal of Radiation Oncology, Biology, Physics|December 31, 2003
Late neointimal tissue growth behind the stent after intravascular gamma-radiationDavid Busseuil, Marianne Zeller, Yves Cottin, et al.
The Journal of Comparative Neurology|January 25, 2006
Localization of the urotensin II receptor in the rat central nervous systemSylvie Jégou, Dorthe Cartier, Christophe Dubessy, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 29, 2003
Synthesis and pharmacological study of Rho-kinase inhibitors: pharmacomodulations on the lead compound FasudilCédric Logé, Xavier Siomboing, Valérie Wallez, et al.
The Journal of Biological Chemistry|August 1, 2002
Neuropeptide AF and FF modulation of adipocyte metabolism. Primary insights from functional genomics and effects on beta-adrenergic responsivenessIsabelle Lefrere, Pierre De Coppet, Jean-Claude Camelin, et al.
Psychopharmacology|September 15, 2005
Behavioral effects of urotensin-II centrally administered in miceJean-Claude Do-Rego, David Chatenet, Marie-Hélène Orta, et al.
Pageof 4